I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Asao, Tetsuhiko
71
results:
Search for persons
X
Format
Online (71)
Mediatypes
Articles (Online) (39)
OpenAccess-fulltext (32)
Sorted by: Relevance
Sorted by: Year
?
1
Phase II Study of Durvalumab Immediately after Completion o..:
Nakamichi, Shinji
;
Kubota, Kaoru
;
Misumi, Toshihiro
...
Clinical Cancer Research. 30 (2024) 6 - p. 1104-1110 , 2024
Link:
https://doi.org/10.1158/..
?
2
Real-World Data on Subsequent Therapy for First-Line Osimer..:
Nishioka, Naoya
;
Imai, Hisao
;
Endo, Masahiro
...
Targeted Oncology. 19 (2024) 3 - p. 423-433 , 2024
Link:
https://doi.org/10.1007/..
?
3
Prognostic impact of adjuvant therapy for cisplatin-unfit p..:
Noritake, Osamu
;
Nakamura, Shota
;
Kinoshita, Fumie
...
Lung Cancer. 188 (2024) - p. 107470 , 2024
Link:
https://doi.org/10.1016/..
?
4
Reconsidering the Cutoff Value for Sensitive and Refractory..:
Torasawa, Masahiro
;
Horinouchi, Hidehito
;
Nomura, Shogo
...
Journal of Thoracic Oncology. 19 (2024) 2 - p. 325-336 , 2024
Link:
https://doi.org/10.1016/..
?
5
Lymphangioleiomyomatosis as a potent lung cancer risk facto..:
Torasawa, Masahiro
;
Shukuya, Takehito
;
Uemura, Kohei
...
Respirology. , 2024
Link:
https://doi.org/10.1111/..
?
6
Usefulness of Computed Tomography for Evaluating the Effect..:
Abe, Sumiko
;
Yasuda, Mina
;
Tobino, Kazunori
...
Journal of Asthma and Allergy. 17 (2024) - p. 325-337 , 2024
Link:
https://doi.org/10.2147/..
?
7
Multicenter Pharmacokinetic and Pharmacodynamic Study of Pe..:
Yagishita, Shigehiro
;
Yamanaka, Yuta
;
Kurata, Takayasu
...
Clinical Pharmacology & Therapeutics. , 2024
Link:
https://doi.org/10.1002/..
?
8
Trophoblast Cell Surface Antigen 2 Expression in Thymic Car..:
Kurokawa, Kana
;
Asao, Tetsuhiko
;
Hayashi, Takuo
...
JTO Clinical and Research Reports. 5 (2024) 7 - p. 100693 , 2024
Link:
https://doi.org/10.1016/..
?
9
Genomic profiling and metastatic risk in early-stage non–sm..:
Fick, Cameron N.
;
Dunne, Elizabeth G.
;
Lankadasari, Manendra B.
...
JTCVS Open. 16 (2023) - p. 9-16 , 2023
Link:
https://doi.org/10.1016/..
?
10
Early Detection of Therapeutic Benefit from PD-1/PD-L1 Bloc..:
Xu, Shiting
;
Miura, Keita
;
Shukuya, Takehito
...
Cancers. 15 (2023) 4 - p. 1170 , 2023
Link:
https://doi.org/10.3390/..
?
11
Study Design and Rationale for Marble Study: A Phase II Tri..:
Asao, Tetsuhiko
;
Shukuya, Takehito
;
Mimori, Tomoyasu
...
Clinical Lung Cancer. 24 (2023) 7 - p. e247-e253 , 2023
Link:
https://doi.org/10.1016/..
?
12
Pneumonitis associated with pembrolizumab plus chemotherapy..:
Fujimoto, Daichi
;
Miura, Satoru
;
Tomii, Keisuke
...
Scientific Reports. 13 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1038/..
?
13
CALML5 is a novel diagnostic marker for differentiating thy..:
Kanamori, Koichiro
;
Suina, Kentaro
;
Shukuya, Takehito
...
Thoracic Cancer. 14 (2023) 12 - p. 1089-1097 , 2023
Link:
https://doi.org/10.1111/..
?
14
Clinical characteristics of adrenal insufficiency induced b..:
Kurokawa, Kana
;
Mitsuishi, Yoichiro
;
Shimada, Naoko
...
Thoracic Cancer. 14 (2022) 5 - p. 442-449 , 2022
Link:
https://doi.org/10.1111/..
?
15
Heterogeneous Outcomes of Immune Checkpoint Inhibitor Recha..:
Xu, Shiting
;
Shukuya, Takehito
;
Tamura, Jun
...
JTO Clinical and Research Reports. 3 (2022) 4 - p. 100309 , 2022
Link:
https://doi.org/10.1016/..
1-15